References
- Brug, J. and Crawford, D. (2009) The obesity pandemic. Is it bad or worse? Eur. J. Public Health 19: 570-571.
- Spielgelman, B. M. and Enerback, S. (2006) The adipocyte: a multifunctional cell. Cell Metab. 4: 425-429. https://doi.org/10.1016/j.cmet.2006.11.009
- Kopelman, P. G. (2000) Obesity as a medical problem. Nature 404: 635-638.
- Lowe, M. E. (1994) Pancreatic triglyceride lipase and colipase: insights into dietary fat digestion. Gastroenterology 107: 1524-1536. https://doi.org/10.1016/0016-5085(94)90559-2
- Ballinger, A. and Peikin, S.R. (2002) Orlistat: its current status as an anti-obesity drug. Eur. J. Pharmacol. 440: 109-117. https://doi.org/10.1016/S0014-2999(02)01422-X
- Birari, R. B. and Bhutani, K. K. (2007) Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov. Today 12: 879-889. https://doi.org/10.1016/j.drudis.2007.07.024
- Yun, J. W. (2010) Possible anti-obesity therapeutics from nature. Phytochemistry 71: 1625-1641. https://doi.org/10.1016/j.phytochem.2010.07.011
- 배기환 (2000) 한국의 약용식물, 213, 교학사, 서울.
- Yang, E. J., Lee, J. S., Yun, C. Y., Kim, J. H., Kim, J. S., Kim, D. H. and Kim, I. S. (2008) Inhibitory effects of Duchesnea chrysantha extract on ovalbumin-induced lung inflammation in mouse model of asthma. J. Ethnopharmacol. 118: 102-107. https://doi.org/10.1016/j.jep.2008.03.012
- Lee, I. R. and Yang, M. Y. (1994) Phenolic compounds from Duchesnea chrysantha and their cytotoxic activities in human cancer cell. Arch. Pharm. Res. 17: 476-479. https://doi.org/10.1007/BF02979129
- Lee, J. S., Kim, I. S., Ryu, J. S., Kim, J. H., Kim, J. S., Kim, D. H. and Yun, C.Y. (2012) The inhibitory effect of Duchesnea chrysantha extract on the development of atopic dermatitis- like lesions by regulating IgE and cytokine production in Nc/Nga mice. Phytother Res. 26: 284-290. https://doi.org/10.1002/ptr.3545
- Lee, I. R., Wee, S. W. and Hang, Y. N. (1989) Studies on the pharmacological actions and biologically active components of Korean traditional medicines (VI). Tannins from Duchesnea indica. Kor. J. Pharmacogn. 20: 110-116.
- Lee, I. R., Hahn, S. H., Han, Y. N. and Jeong, G. (1990) Studies on the pharmacological actions and biologically active components of Korean traditional medicines (VII). On the anticancer macromolecular substances from Duchesnea indica Herba. Kor. J. Pharmacogn. 21: 186-192.
- Ahn, J. H., Liu, Q., Lee, C., Ahn, M. J., Yoo, H. S., Hwang, B. Y. and Lee, M. K. (2012) A new pancreatic lipase inhibitory from Broussonetia kanzinoki. Bioorg. Med. Chem. Lett. 22: 2760-2763. https://doi.org/10.1016/j.bmcl.2012.02.088
- Hamerski, L., Bomm, M. D., Silva, D. H. S., Young, M. C. M., Furlan, M., Eberlin, M. N., Castro-Gamboa, I., Cavalheiro, A. J. and Bolzani, V. S. (2005) Phenylpropanoid glucosides from leaves of Coussarea hydrangeifolia (Rubiaceae) Phytochemistry 66: 1927-1932. https://doi.org/10.1016/j.phytochem.2005.06.019
- Tsukamoto, S., Tomise, K., Aburatani, M., Onuki, H., Hirota, H., Ishiharajima, E. and Ohta, T. (2004) Isolation of cytochrome p450 inhibitors from strawberry fruit, Fragaria ananassa. J. Nat. Prod. 67: 1839-1841. https://doi.org/10.1021/np0400104
- Lin, C. N., Kuo, S. H., Chung, M. I., Ko, F. N. and Teng, C. M. (1997) A new flavone C-glycoside and antiplatelet and vasorelaxing flavones from Gentiana arisanensis. J. Nat. Prod. 60: 851-853. https://doi.org/10.1021/np970011e
- Choi, H. G., Jiang, Y., Park, S. H., Son, S. R., Na, M. K. and Lee, S. H. (2011) Constituents of flowers of Carthamus tinctorius L. and their antioxidant activity. Kor. J. Pharmacogn. 42: 110-116.
- Yang, S., Park, S., Ahn, D., Yang, J. H., Cho, C. H., Hwang, Y. H., Park, J. H. and Kim, D. K. (2010) DPPH free radical scavenging effect of the aerial parts of Desmodium oldhami. Kor. J. Pharmacogn. 41: 180-184.
-
Oyama, K. and Kondo, T. (2004) Total synthesis of apigenin 7,4'-di-O-
${\beta}$ -glucopyranoside, a component of blue flower pigment of Salvia patens, and seven chiral analogues. Tetrahedron 60: 2025-2034. https://doi.org/10.1016/j.tet.2004.01.001 - Kato, H., Li, W., Koike, M., Wang, Y. and Koike, K. (2010) Phenolic glycosides from Agrimonia pilosa. Phytochemistry 71: 1925-1929. https://doi.org/10.1016/j.phytochem.2010.08.007
- Ninomiya, K., Matsuda, H., Kubo, J., Morikawa, T., Nishida, N. and Yoshikawa, M. (2007) Potent-anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside. Bioorg. Med. Chem. Lett. 17: 3059-3064. https://doi.org/10.1016/j.bmcl.2007.03.051
- Qiao, W., Zhao, C., Qin, N., Zhai, H. Y. and Duan, H. Q. (2011) Identification of trans-tiliroside as active principle with anti-hyperglycemic, anti-hyperlipidemic and antioxidant effects from Potentilla chinensis. J. Ethnopharmacol. 135: 515-521. https://doi.org/10.1016/j.jep.2011.03.062
- Sala, A., Recio, M. C., Schinella, G. R., Manez, S., Giner, R. M., Cerda-Nicolas M. and Rosi, J. L. (2003) Assessment of the anti-inflammatory activity and free radical scavenger activity of tiliroside. Eur. J. Pharmacol. 461: 53-61. https://doi.org/10.1016/S0014-2999(02)02953-9
- Rao, Y. K., Fang, S. H., Tzeng, Y. M. (2005) Inhibitory effects of the flavonoids isolated from Waltheria indica on the production of NO, TNF-a and IL-12 in activated macrophages. Biol. Pharm. Bull. 28: 912-915. https://doi.org/10.1248/bpb.28.912
- Matsuda, H., Ninomiya, K., Shimoda, H. and Yoshikawa, M. (2002) Hepatoprotective principles from the flowers of Tilia argentea (linden): structure requirements of riliroside and mechanisms of action. Bioorg. Med. Chem. 10: 707-712. https://doi.org/10.1016/S0968-0896(01)00321-2
- Goto, T., Teraminami, A., Lee, J. Y., Ohyama, K., Funakoshi, K., Kim, Y. I., Hirai, S., Uemura, T., Yu, R., Takahashi, N. and Kawada, T. (2012) Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice. J. Nutr. Biochem. 23: 768-776. https://doi.org/10.1016/j.jnutbio.2011.04.001